ReviewCurrent pharmaceutical biotechnology2018

Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma.

Ryan L Setten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.